Side Effects Of Monoclonal Antibody Therapy

In general monoclonal antibody treatment carries fewer side effects than do traditional chemotherapy treatments.

Side effects of monoclonal antibody therapy.

Monoclonal antibodies can cause side effects which can differ from person to person. Some people may have a reaction e g. Monoclonal antibodies are biological drugs used to treat cancers certain types of arthritis lupus ms and ibd. Side effects of monoclonal antibody therapy.

However administration of mabs carries the risk of immune reactions such as acute anaphylaxis serum sickness and. Your doctor will discuss any potential side effects with you before you start treatment. The most common monoclonal antibody therapies for managing colon cancer are bevacizumab avastin cetuximab erbitux and. Monoclonal antibodies are increasingly becoming a standard part of clinical cancer treatment.

Eight monoclonal antibodies are approved by the food and drug administration for the treatment of cancer in the united states. Side effects are itching rash chills cough and constipation and may include hepatitis cancer and congestive heart failure. Talk to your doctor about what side effects are associated with the particular drug you re receiving. An antibody is a protein that sticks to a specific protein called an antigen.

You will probably be given medicine to help prevent such a reaction and you will have. The ones you may have and how they make you feel will depend on many factors such as how healthy you are before treatment your type of cancer how advanced it is the type of monoclonal antibody you are receiving and the dose. Monoclonal antibody therapy is a targeted cancer therapy it is sometimes called immunotherapy. However monoclonal antibody treatment for cancer may cause side effects some of which though rare can be very serious.

Nausea skin rashes and itching during or several hours after having these drugs. While surgery chemotherapy and radiation therapy remain important treatment options for colon cancer monoclonal antibody therapy is becoming more widely available for use.